Pyoderma gangrenosum

From IDWiki
Revision as of 17:20, 27 September 2024 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

Subtypes

  • Ulcerative: ulceration with rapidly-evolving purulent wound
  • Pustular: discrete pustules, sometimes self-limited, and most commonly associated with inflammatory bowel disease
  • Bullous: superficial bullae with ulcerations
  • Vegetative: erosions with superficial ulcers

Associated Disorders

Clinical Manifestations

  • Chronic wound, most commonly on lower legs in the pretibial area
  • Can occur anywhere on the body, particularly at surgical sites
  • Rarely, can involve upper airway, eye, genital mucosa, lung (sterile neutrophilic pulmonary infiltrates), splenic infiltrates, myositis, and sterile osteolysis

Diagnosis

Diagnostic Criteria1

  • Major criterion:
    • Biopsy of ulcer edge demonstrating a neutrophilic infiltrate
  • Minor criteria:
    • Exclusion of infection
    • Pathergy
    • Personal history of inflammatory bowel disease or inflammatory arthritis
    • History of papule, pustule, or vesicle that rapidly ulcerated
    • Peripheral erythema, undermining border, and tenderness at site of ulceration
    • Multiple ulcerations (at least one occurring on an anterior lower leg)
    • Cribriform or "wrinkled paper" scar(s) at sites of healed ulcers
    • Decrease in ulcer size within one month of initiating immunosuppressive medications
  • Interpretation:
    • Positive if at the major criterion and at least four minor criteria are present

Further Reading

References

  1. ^  Emanual Maverakis, Chelsea Ma, Kanade Shinkai, David Fiorentino, Jeffrey P. Callen, Uwe Wollina, Angelo Valerio Marzano, Daniel Wallach, Kyoungmi Kim, Courtney Schadt, Anthony Ormerod, Maxwell A. Fung, Andrea Steel, Forum Patel, Rosie Qin, Fiona Craig, Hywel C. Williams, Frank Powell, Alexander Merleev, Michelle Y. Cheng. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum. JAMA Dermatology. 2018;154(4):461. doi:10.1001/jamadermatol.2017.5980.